Viewing Study NCT02581020


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-03-02 @ 4:54 PM
Study NCT ID: NCT02581020
Status: COMPLETED
Last Update Posted: 2021-12-08
First Post: 2015-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-01-14
Start Date Type: ACTUAL
Primary Completion Date: 2020-12-08
Primary Completion Date Type: ACTUAL
Completion Date: 2020-12-08
Completion Date Type: ACTUAL
First Submit Date: 2015-10-19
First Submit QC Date: None
Study First Post Date: 2015-10-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-12-06
Last Update Post Date: 2021-12-08
Last Update Post Date Type: ACTUAL